USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
11 Aug 2022 | 02:45 PM GMT

Masterclass: Value, Cost and Pricing in Regulated Digital Health Solutions

Anchored by:

David Matthews
Chief Growth Officer
BRIGHTINSIGHT, INC.

Participants:

David Matthews Chief Growth OfficerBrightInsight, Inc.
David Matthews
Chief Growth OfficerBrightInsight, Inc.
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Cheryl Behr ConsultantCB Consulting
Cheryl Behr
ConsultantCB Consulting
Chris Wasden Chief Strategy OfficerTwill
Chris Wasden
Chief Strategy OfficerTwill
Ekta Foster-Lachmandas Digital Health Business CreationRoche Diagnostics
Ekta Foster-Lachmandas
Digital Health Business CreationRoche Diagnostics
Gregoire Guillet Chief Business and Value OfficerWeHealth Digital Medicine
Gregoire Guillet
Chief Business and Value OfficerWeHealth Digital Medicine
Mike Pace Founder & CEOPalmHealthCo
Mike Pace
Founder & CEOPalmHealthCo
Ricardo C. Berrios Co-Founder & CEOAdhera Health, Inc.
Ricardo C. Berrios
Co-Founder & CEOAdhera Health, Inc.
Rich DeNunzio Chief Commercial OfficerClick Therapeutics
Rich DeNunzio
Chief Commercial OfficerClick Therapeutics
Thyago Ohana Digital Strategy & Capabilities LeadUCB Pharma
Thyago Ohana
Digital Strategy & Capabilities LeadUCB Pharma

About this Meeting

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. However, most times the reality of costs and timelines associated with building, scaling and maintaining regulated digital health products, don’t match the initial expectations.

While the investments in SaMD can be large and exceed both cost and time estimates, there is an opportunity to generate significant returns from these solutions if you are able to demonstrate the value, lower cost and time to market and build the right pricing model for the solution. Join this masterclass led by David Matthews, PhD,  Chief Customer Officer at BrightInsight, will walk us through:  

  • Demonstrating the value of digital health: these solutions can provide a range of benefits to patients, clinicians, and many others in the ecosystem of patient treatment and care. How do you show - qualitatively and quantitatively - the tangible value of novel digital solutions? 
  • Cost considerations in SaMD: building software as medical devices typically costs 5 times more than originally planned and takes 3 times longer. How do you lower the cost and time to market? 
  • Pricing models: considering the value of a digital health solution, its development cost and timelines, how can we build the right pricing model for the solution? How can digital health offerings leverage pricing models to ensure ROI for them and for the other stakeholders in the ecosystem?